Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical StudyMichèle Cavo, Michele Baccarani, Patrizia Tosi et al.|Journal of Clinical Oncology|2007Cited by 374
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.Patrizia Tosi, Michèle Cavo, Elena Zamagni et al.|PubMed|2002Cited by 111
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label studyPaola Tacchetti, Gianpietro Semenzato, Lucia Pantani et al.|The Lancet Haematology|2020Cited by 58
CART-Cell Therapy: Recent Advances and New Evidence in Multiple MyelomaMassimo Martino, Claudio Cerchione, Filippo Antonio Canale et al.|Cancers|2021Cited by 38
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)Domenico Russo, Anna Paola Iori, Domenico Pastore et al.|Bone Marrow Transplantation|2021Cited by 20